Fmr LLC Nektar Therapeutics Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Fmr LLC holds 76,834 shares of NKTR stock, worth $107,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,834

Previous 125,445 38.75%

Holding current value

$107,567

Previous $116,000 18.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.9 - $1.83 $43,749 - $88,958	-48,611 Reduced 38.75%	76,834 $95,000
Q1 2024 May 13, 2024	SELL	$0.49 - $0.96 $596 - $1,169	-1,218 Reduced 0.96%	125,445 $116,000
Q4 2023 Feb 13, 2024	BUY	$0.42 - $0.57 $21,011 - $28,515	50,028 Added 65.28%	126,663 $70,000
Q3 2023 Nov 13, 2023	SELL	$0.51 - $1.05 $128,276 - $264,098	-251,522 Reduced 76.65%	76,635 $45,000
Q2 2023 Aug 11, 2023	SELL	$0.53 - $1.03 $54,737 - $106,377	-103,279 Reduced 23.94%	328,157 $190,000
Q1 2023 May 11, 2023	BUY	$0.64 - $3.15 $2,456 - $12,089	3,838 Added 0.9%	431,436 $302,000
Q4 2022 Feb 13, 2023	SELL	$2.03 - $4.28 $68,695 - $144,835	-33,840 Reduced 7.33%	427,598 $966,000
Q3 2022 Nov 10, 2022	BUY	$3.04 - $5.14 $821,104 - $1.39 Million	270,100 Added 141.16%	461,438 $1.48 Million
Q2 2022 Aug 12, 2022	SELL	$3.17 - $6.17 $185,552 - $361,154	-58,534 Reduced 23.43%	191,338 $727,000
Q1 2022 May 13, 2022	SELL	$4.16 - $13.72 $27.1 Million - $89.3 Million	-6,509,332 Reduced 96.3%	249,872 $1.35 Million
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $78.5 Million - $133 Million	-7,248,541 Reduced 51.75%	6,759,204 $91.3 Million
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $24.1 Million - $34.7 Million	-1,840,557 Reduced 11.61%	14,007,745 $252 Million
Q2 2021 Aug 13, 2021	BUY	$16.52 - $20.4 $262 Million - $323 Million	15,848,302 New	15,848,302 $272 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

134M

Call Options Held

32.8K

Put Options Held

55.5K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $262M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account